
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates

Cranberry and its extracts are popular choices for managing Cranberry for pet UTIs, yet clinical guidance remains scarce. Many pet owners turn to these supplements to prevent or treat urinary tract diseases in dogs and cats. However, a recent systematic review suggests that the scientific backing for this practice is quite limited. Consequently, veterinarians and pet owners should exercise caution when relying solely on these products.
Researchers conducted a comprehensive systematic review to assess the effectiveness of cranberry supplementation. The study focused on bacterial cystitis and subclinical bacteriuria in 122 animals, including 106 dogs and 16 cats. Interestingly, none of the identified studies reported statistically significant impacts on treatment outcomes. Furthermore, the researchers noted that the numerical impacts were also negligible. Therefore, the role of cranberry in treating active infections remains unproven.
The review highlighted several concerns regarding the quality of existing literature. Among the three studies identified, researchers deemed two at high risk of bias. Only one study maintained a low risk profile. Moreover, the overall certainty of evidence was low to very low. In addition, small sample sizes prevent experts from making confident clinical recommendations. Because of these factors, more rigorous research is necessary to define the therapeutic value of cranberry for domestic animals.
Ultimately, the small number of available studies precludes a definitive assessment of cranberry’s role in pet urinary health. While in vitro studies often show that proanthocyanidins inhibit bacterial adhesion, these results have not translated into strong clinical outcomes in cats and dogs. Consequently, practitioners should prioritize evidence-based treatments while further research unfolds.
Current systematic reviews indicate that there is no statistically significant evidence to support using cranberry as a primary treatment for infectious urinary tract disease in dogs.
While cranberry is safe in small amounts for many cats, the latest evidence shows very low certainty regarding its efficacy in preventing or treating feline bacterial cystitis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical or veterinary advice. Refer to the latest local and national guidelines for clinical practice.
References
Weese JS et al. Effectiveness of Cranberry Supplementation for Prevention and Treatment of Infectious Urinary Tract Disease in Dogs and Cats: A Systematic Review. J Vet Pharmacol Ther. 2026 Feb 12. doi: 10.1111/jvp.70050. PMID: 41676867.
Chou HI et al. Effects of cranberry extract on prevention of urinary tract infection in dogs. Am J Vet Res. 2016;77(4):421-427.
Olby NJ et al. Effect of Cranberry Extract on the Frequency of Bacteriuria in Dogs with Acute Thoracolumbar Disk Herniation. J Vet Intern Med. 2017;31(1):60-67.

Systematic review finds low evidence for cranberry supplementation in treating or preventing infectious urinary tract disease in dogs and cats....
4 months ago

Rucaparib (Rubraca) is the first FDA-approved PARP inhibitor for BRCA-mutated mCRPC. Evidence from the TRITON trials shows that it significantly improves radiographic progression-free survival compared to docetaxel, providing a potent and manageable oral alternative to standard chemotherapy.
Today

Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
Today

A new study by Pacific OneHealth Hospitals reveals that over 50% of millennials in Delhi-NCR are overweight or obese. It highlights a critical metabolic health risk window between ages 30 and 44, during which visceral fat accumulation and hypertension rise sharply, driving future cardiovascular diseases.
Today

This study explores atomic-scale techniques like PEALD to engineer ZnO-Chitosan biointerfaces for medical implants. These interfaces exhibit superior immunomodulatory properties and antiseptic activity against pathogens, marking a significant advancement for next-generation medical devices.
Today

A large-scale retrospective study reveals systematic biases in POC glucose meters compared to laboratory methods. Findings show that anaemia significantly amplifies negative bias at high glucose levels, suggesting a need for confirmatory testing in high-risk inpatient scenarios.
Today